309 related articles for article (PubMed ID: 25934649)
1. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
2. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
3. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
5. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
Yuta A; Ogihara H; Miyamoto Y; Takeuchi K; Okubo K
Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
[TBL] [Abstract][Full Text] [Related]
6. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
8. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
10. Increased Thrombin-Activatable Fibrinolysis Inhibitor in Response to Sublingual Immunotherapy for Allergic Rhinitis.
Yoshida K; Takabayashi T; Imoto Y; Sakashita M; Kato Y; Narita N; Fujieda S
Laryngoscope; 2021 Nov; 131(11):2413-2420. PubMed ID: 33844301
[TBL] [Abstract][Full Text] [Related]
11. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
Tofukuji S; Ishida S; Katayama K
Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
[No Abstract] [Full Text] [Related]
12. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
13. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
[TBL] [Abstract][Full Text] [Related]
14. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
[TBL] [Abstract][Full Text] [Related]
16. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
[TBL] [Abstract][Full Text] [Related]
17. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
18. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Takeda N
J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
[TBL] [Abstract][Full Text] [Related]
19. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui T; Masuda S; Yamaguchi M; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():47-53. PubMed ID: 18504407
[TBL] [Abstract][Full Text] [Related]
20. Cytokine Responses to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients.
Li H; Xu E; He M
Inflammation; 2015 Dec; 38(6):2216-23. PubMed ID: 26122703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
